Early Discontinuation of P2Y(12) Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort

BACKGROUND: Early discontinuation of P2Y(12) antagonists post–percutaneous coronary intervention may increase risk of stent thrombosis or nonstent recurrent myocardial infarction. Our aims were to (1) analyze the early discontinuation rate of P2Y(12) antagonists post–percutaneous coronary interventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Daniel E., Lacey, Arron, Akbari, Ashley, Obaid, Daniel R., Smith, Dave A., Jenkins, Geraint H., Barry, James P., Gravenor, Mike B., Halcox, Julian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898825/
https://www.ncbi.nlm.nih.gov/pubmed/31658860
http://dx.doi.org/10.1161/JAHA.119.012812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898825/
https://www.ncbi.nlm.nih.gov/pubmed/31658860
http://dx.doi.org/10.1161/JAHA.119.012812

Ejemplares similares